Hitomi Ogino, Legal Representative

Title: Hitomi Ogino - Innovator in Pharmaceutical Compounds

Introduction

Hitomi Ogino is a distinguished inventor and legal representative based in Toyonaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cephem compounds. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Hitomi Ogino holds a patent for cephem compounds, which relates to a compound of the formula [I]. In this invention, A is defined as lower alkylene or lower alkenylene, while R can be lower alkyl, hydroxy(lower)alkyl, protected hydroxy(lower)alkyl, amino(lower)alkyl, or protected amino(lower)alkyl. The patent also describes R as hydrogen or an amino protecting group, with the possibility of R and R being bonded together to form lower alkylene. Additionally, R and R can independently be amino or protected amino, and R can be carboxy or protected carboxy, or a pharmaceutically acceptable salt thereof. The patent outlines a process for preparing this compound and a pharmaceutical composition that includes it in admixture with a pharmaceutically acceptable carrier. She has 1 patent to her name.

Career Highlights

Throughout her career, Hitomi Ogino has worked with notable companies in the pharmaceutical industry. She has been associated with Astellas Pharma GmbH and Wakunaga Pharmaceutical Co., Ltd., where she has contributed her expertise in drug development and innovation. Her work has been instrumental in advancing pharmaceutical research and applications.

Collaborations

Hitomi has collaborated with esteemed colleagues, including Hidenori Ohki and Shinya Okuda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Hitomi Ogino is a remarkable inventor whose contributions to pharmaceutical compounds have made a significant impact in the industry. Her dedication to innovation and collaboration continues to inspire advancements in medical science.